Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | PLA2G4A |
| Upstream (Parents) |
|---|
| (<<) BAALC → PLA2G4A |
| (<<) BLNK → PLA2G4A |
| (<<) BMP2 → PLA2G4A |
| (<<) CAV3 → PLA2G4A |
| (<<) CEBPA → PLA2G4A |
| (<<) CMTM7 → PLA2G4A |
| (<<) DUSP1 → PLA2G4A |
| (<<) FZD2 → PLA2G4A |
| (<<) FZD9 → PLA2G4A |
| (<<) GPX4 → PLA2G4A |
| (<<) HDAC8 → PLA2G4A |
| (<<) HLA-DOA → PLA2G4A |
| (<<) IL6 → PLA2G4A |
| (<<) KRT6B → PLA2G4A |
| (<<) MAP3K5 → PLA2G4A |
| (<<) MEGF6 → PLA2G4A |
| (<<) MTMR6 → PLA2G4A |
| (<<) MTRR → PLA2G4A |
| (<<) NRAS → PLA2G4A |
| (<<) PNO1 → PLA2G4A |
| (<<) PRDX6 → PLA2G4A |
| (<<) PTGER1 → PLA2G4A |
| (<<) PTGS2 → PLA2G4A |
| (<<) RAB7B → PLA2G4A |
| (<<) S100A2 → PLA2G4A |
| (<<) SH3KBP1 → PLA2G4A |
| (<<) ST3GAL6 → PLA2G4A |
| Downstream (Children) |
|---|
| PLA2G4A → CALML5 (>>) |
| PLA2G4A → CLCA4 (>>) |
| PLA2G4A → GRK5 (>>) |
| PLA2G4A → HIST1H3J (>>) |
| PLA2G4A → LRRC8C (>>) |
| PLA2G4A → PPP3CA (>>) |
| PLA2G4A → PROCR (>>) |
| PLA2G4A → SGK1 (>>) |
| PLA2G4A → ZNF575 (>>) |
